{
  "issues": [
    "The selected protocol CT_TRAUMA_CHEST_ABD_PELVIS includes abdomen and pelvis imaging which is unnecessary for isolated thoracic aortic injury and may increase contrast volume.",
    "Agent 2 recommends a split‑bolus technique, which can compromise optimal arterial phase opacification needed for precise aortic injury assessment.",
    "Renal tool notes missing BMI; without patient weight the contrast dose cannot be accurately weight‑based, potentially leading to over‑ or under‑dosing.",
    "Aggressive 1 L pre‑contrast hydration may be excessive in a hemodynamically unstable patient; fluid bolus should be titrated to the patient’s volume status and cardiac function.",
    "Vasopressor support is advised but the target MAP ≥65 mmHg may be difficult to achieve immediately; the recommendation should emphasize cautious titration and reassessment before contrast administration."
  ],
  "recommendations": [
    "Select a dedicated thoracic aorta CT angiography protocol (e.g., CT_TA_ANGIO) with arterial phase timing and optional delayed images for endoleak assessment.",
    "Obtain the patient’s weight (and height to calculate BMI) to enable weight‑based contrast dosing (≈1.5 mL/kg of low‑osmolar or iso‑osmolar iodinated contrast).",
    "Stabilize hemodynamics with vasopressor support, aiming for MAP ≥65 mmHg, but titrate slowly and reassess after achieving a stable MAP before administering contrast.",
    "Administer a modest isotonic saline bolus (e.g., 500 mL over 15–30 min) if the patient is not volume overloaded, followed by continued maintenance fluids post‑contrast, monitoring central venous pressure or bedside ultrasound as needed.",
    "Use low‑osmolar (or iso‑osmolar) contrast agents and avoid split‑bolus techniques; instead use a single arterial bolus with bolus‑tracking to ensure optimal aortic opacification.",
    "Document pre‑ and post‑contrast serum creatinine (even though baseline is excellent) and monitor urine output for 24 h after the study.",
    "If MAP cannot be safely raised, consider alternative imaging (e.g., transesophageal echocardiography or MRI) that does not require iodinated contrast."
  ],
  "confidence": 0.76,
  "agent2_confidence": 0.45,
  "timestamp": "2025-08-26T10:42:38.897446Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-08-26T10:42:30.112159Z",
          "priority": "critical",
          "value": 135.1,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-08-26T10:42:30.112173Z",
          "priority": "critical",
          "value": 0.5,
          "status": "pass",
          "reason": "Creatinine within normal range."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-08-26T10:42:30.112181Z",
          "priority": "important",
          "value": 16.0,
          "status": "pass",
          "reason": "BUN/Cr ratio normal."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-08-26T10:42:30.112193Z",
          "priority": "important",
          "value": 3.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "pass",
        "reasons": [
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.92
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-08-26T10:42:30.112229Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"The selected protocol CT_TRAUMA_CHEST_ABD_PELVIS includes abdomen and pelvis imaging which is unnecessary for isolated thoracic aortic injury and may increase contrast volume.\",\n    \"Agent 2 recommends a split‑bolus technique, which can compromise optimal arterial phase opacification needed for precise aortic injury assessment.\",\n    \"Renal tool notes missing BMI; without patient weight the contrast dose cannot be accurately weight‑based, potentially leading to over‑ or under‑dosing.\",\n    \"Aggressive 1 L pre‑contrast hydration may be excessive in a hemodynamically unstable patient; fluid bolus should be titrated to the patient’s volume status and cardiac function.\",\n    \"Vasopressor support is advised but the target MAP ≥65 mmHg may be difficult to achieve immediately; the recommendation should emphasize cautious titration and reassessment before contrast administration.\"\n  ],\n  \"recommendations\": [\n    \"Select a dedicated thoracic aorta CT angiography protocol (e.g., CT_TA_ANGIO) with arterial phase timing and optional delayed images for endoleak assessment.\",\n    \"Obtain the patient’s weight (and height to calculate BMI) to enable weight‑based contrast dosing (≈1.5 mL/kg of low‑osmolar or iso‑osmolar iodinated contrast).\",\n    \"Stabilize hemodynamics with vasopressor support, aiming for MAP ≥65 mmHg, but titrate slowly and reassess after achieving a stable MAP before administering contrast.\",\n    \"Administer a modest isotonic saline bolus (e.g., 500 mL over 15–30 min) if the patient is not volume overloaded, followed by continued maintenance fluids post‑contrast, monitoring central venous pressure or bedside ultrasound as needed.\",\n    \"Use low‑osmolar (or iso‑osmolar) contrast agents and avoid split‑bolus techniques; instead use a single arterial bolus with bolus‑tracking to ensure optimal aortic opacification.\",\n    \"Document pre‑ and post‑contrast serum creatinine (even though baseline is excellent) and monitor urine output for 24 h after the study.\",\n    \"If MAP cannot be safely raised, consider alternative imaging (e.g., transesophageal echocardiography or MRI) that does not require iodinated contrast.\"\n  ],\n  \"confidence\": 0.86\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "The selected protocol CT_TRAUMA_CHEST_ABD_PELVIS includes abdomen and pelvis imaging which is unnecessary for isolated thoracic aortic injury and may increase contrast volume.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 recommends a split‑bolus technique, which can compromise optimal arterial phase opacification needed for precise aortic injury assessment.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Renal tool notes missing BMI; without patient weight the contrast dose cannot be accurately weight‑based, potentially leading to over‑ or under‑dosing.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Aggressive 1 L pre‑contrast hydration may be excessive in a hemodynamically unstable patient; fluid bolus should be titrated to the patient’s volume status and cardiac function.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Vasopressor support is advised but the target MAP ≥65 mmHg may be difficult to achieve immediately; the recommendation should emphasize cautious titration and reassessment before contrast administration.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Select a dedicated thoracic aorta CT angiography protocol (e.g., CT_TA_ANGIO) with arterial phase timing and optional delayed images for endoleak assessment.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain the patient’s weight (and height to calculate BMI) to enable weight‑based contrast dosing (≈1.5 mL/kg of low‑osmolar or iso‑osmolar iodinated contrast).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Stabilize hemodynamics with vasopressor support, aiming for MAP ≥65 mmHg, but titrate slowly and reassess after achieving a stable MAP before administering contrast.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Administer a modest isotonic saline bolus (e.g., 500 mL over 15–30 min) if the patient is not volume overloaded, followed by continued maintenance fluids post‑contrast, monitoring central venous pressure or bedside ultrasound as needed.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "Use low‑osmolar (or iso‑osmolar) contrast agents and avoid split‑bolus techniques; instead use a single arterial bolus with bolus‑tracking to ensure optimal aortic opacification.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document pre‑ and post‑contrast serum creatinine (even though baseline is excellent) and monitor urine output for 24 h after the study.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "If MAP cannot be safely raised, consider alternative imaging (e.g., transesophageal echocardiography or MRI) that does not require iodinated contrast.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 11,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 1,
      "contradicted": 0
    },
    "hallucination_score": 0.042,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.1
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 10014729.0,
        "hadm_id": 28889419.0,
        "stay_id": 33558396.0,
        "age": 21.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 2.47,
        "los_icu_days": 2.47,
        "creatinine_mg_dl": 0.5,
        "bun_mg_dl": 8.0,
        "glucose_mg_dl": 76.0,
        "hemoglobin_g_dl": 10.3,
        "hematocrit_pct": 29.9,
        "platelet_count": 229.0,
        "wbc_count": 6.9,
        "sodium_meq_l": 137.0,
        "potassium_mmol_l": 3.6,
        "chloride_meq_l": 97.0,
        "bicarbonate_meq_l": 25.0,
        "egfr_ckd_epi": 135.1,
        "ckd_stage": 1.0,
        "bun_creatinine_ratio": 16.0,
        "heart_rate_bpm": 107.0,
        "systolic_bp_mmhg": 78.0,
        "diastolic_bp_mmhg": 35.0,
        "map_mmhg": 49.3,
        "pulse_pressure_mmhg": 43.0,
        "temperature_f": 99.1,
        "spo2_pct": 98.0,
        "respiratory_rate": 18.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "135.1",
        "33558396",
        "creatinine within normal range.",
        "43.0",
        "0.95",
        "49.3",
        "stage 1 (normal)",
        "bun/cr ratio normal.",
        "injury to thoracic aorta",
        "229.0"
      ]
    }
  },
  "feedback": {
    "issues": [
      "The selected protocol CT_TRAUMA_CHEST_ABD_PELVIS includes abdomen and pelvis imaging which is unnecessary for isolated thoracic aortic injury and may increase contrast volume.",
      "Agent 2 recommends a split‑bolus technique, which can compromise optimal arterial phase opacification needed for precise aortic injury assessment.",
      "Renal tool notes missing BMI; without patient weight the contrast dose cannot be accurately weight‑based, potentially leading to over‑ or under‑dosing.",
      "Aggressive 1 L pre‑contrast hydration may be excessive in a hemodynamically unstable patient; fluid bolus should be titrated to the patient’s volume status and cardiac function.",
      "Vasopressor support is advised but the target MAP ≥65 mmHg may be difficult to achieve immediately; the recommendation should emphasize cautious titration and reassessment before contrast administration."
    ],
    "recommendations": [
      "Select a dedicated thoracic aorta CT angiography protocol (e.g., CT_TA_ANGIO) with arterial phase timing and optional delayed images for endoleak assessment.",
      "Obtain the patient’s weight (and height to calculate BMI) to enable weight‑based contrast dosing (≈1.5 mL/kg of low‑osmolar or iso‑osmolar iodinated contrast).",
      "Stabilize hemodynamics with vasopressor support, aiming for MAP ≥65 mmHg, but titrate slowly and reassess after achieving a stable MAP before administering contrast.",
      "Administer a modest isotonic saline bolus (e.g., 500 mL over 15–30 min) if the patient is not volume overloaded, followed by continued maintenance fluids post‑contrast, monitoring central venous pressure or bedside ultrasound as needed.",
      "Use low‑osmolar (or iso‑osmolar) contrast agents and avoid split‑bolus techniques; instead use a single arterial bolus with bolus‑tracking to ensure optimal aortic opacification.",
      "Document pre‑ and post‑contrast serum creatinine (even though baseline is excellent) and monitor urine output for 24 h after the study.",
      "If MAP cannot be safely raised, consider alternative imaging (e.g., transesophageal echocardiography or MRI) that does not require iodinated contrast."
    ],
    "confidence": 0.76
  }
}